HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by de LUISE, M. Articles by MELICK, R. A. Search for Related Content PubMed Articles by de LUISE, M. Articles by MELICK, R. A.

When [¹²⁵I]calcitonin was injected intravenously into rats the major site of accumulation of radioactivity was the liver, whereas [¹²⁵I]parathyroid hormone was localized chiefly in the kidney.

The distribution of [¹²⁵I]bovine serum albumin and of Na [¹²⁵I] was studied for comparison. Although most of the radioactivity of [¹²⁵I]calcitonin was found in the soluble fractions of liver and kidney, significant binding to liver microsomes occurred. This fraction also bound an appreciable amount of the radioactivity of [¹²⁵I]parathyroid hormone. The uptake of [¹²⁵I]calcitonin by liver could be inhibited by the simultaneous injection of unlabelled calcitonin, but not by that of parathyroid hormone, insulin or adrenocorticotrophic hormone.

These results indicate a role for the liver and kidney in the early clearance of calcitonin and parathyroid hormone respectively. It is likely that the liver is the major site of the metabolism of calcitonin in vivo.